AstraZeneca announces Rs 176 crore investments in India to expand Chennai GITC
Chennai: Global biopharmaceutical giant AstraZeneca has announced fresh investments of Rs 176 crore in India, reinforcing its commitment to healthcare innovation and technology. The announcement was made during the Tamil Nadu government’s “TN Rising” campaign in London, coinciding with Chief Minister M.K. Stalin’s visit to the United Kingdom.
The investment will expand the Global Innovation and Technology Centre’s infrastructure and capabilities to strengthen its position as a leader in healthcare innovation both globally and in India, a company statement said here on Saturday.
It is the third investment by AstraZeneca after it announced investments of Rs 166 crore in June towards the establishment of a state-of-the-art Global Hub in Bengaluru.
Read also: AstraZeneca expands Global Hub in Bangalore with Rs 166 crore investment
In July 2024, AstraZeneca announced investments of Rs 250 crore towards expanding the Global Innovation and Technology Centre in Chennai.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.